HealthImaging (5/14, Rohman) reports that a study indicates “more than 40 percent of women with dense breasts will choose to forgo supplemental breast MRI after receiving a negative mammography screening.” Investigators “found that reasons for non-participation were “MRI-related inconveniences,” such as claustrophobia or refusing contrast agent, and anxiety about supplemental screenings.” The findings were published in Clinical Radiology.
Aunt Minnie (5/10) reports that the FDA has cleared Faxitron Bioptics’ “VisionCT clinical CT scanner for intraoperative margin assessment of breast biopsies and lumpectomies.” The system involves “a motorized, 360° rotating platform that can acquire up to six high-resolution images per second, reconstructing the specimen in up to 1,024 slices at a standard slice thickness of 100 microns.”
The Radiology Business Journal (5/8, Walter) reports on a study published in Academic Radiology finding “no statistically significant difference” between screening digital breast tomosynthesis (DBT) examinations immediately, or after the patient has left. While “prior research has shown” immediate screening “results in a higher rate of false positives,” the researchers argued “stress related to being called back for additional imaging is reduced in patients given immediate results who receive immediate additional imaging” and “The vast majority of patients prefer immediate results of their screening mammogram” according to the researchers.
Aunt Minnie (5/8) reports on an online survey of 500 California women ages 40 to 74 who had mammography screening with the last two years conducted by Are You Dense Advocacy, showing that “California women want their state’s breast density notification law to stay on the books.” The law, SB 1538, will expire January 1, 2019, if it is not amended. Sen. Holly Mitchell (D-Los Angeles) has proposed legislation “to eliminate this expiration date.” The survey found that “95% of respondents want the breast density reporting law to remain.”
Medscape (5/8, Jenkins, Subscription Publication) reports on a presentation by Elisa Port, MD, chief of breast surgery at Mount Sinai Hospital and director of the Dubin Breast Center, New York City, NY, at the annual meeting of the American Society of Breast Surgeons. Port said, “I worry that doing fewer mammograms now is being pennywise and pound foolish.” Port added, “Not doing mammograms because of cost or fear of false-positives is a decision that is likely to blow up later when women face more extensive therapy, including surgery and chemotherapy.” Port favors annual mammograms beginning at age 40. She buttressed her argument with “data from a single-center retrospective study of more than 1000 women with breast cancer” finding that “screening mammography within 24 months of diagnosis was associated with smaller tumors overall and a lower likelihood of mastectomy, chemotherapy, or axillary node dissection compared with screening performed at an interval of 25 months or longer, or not at all.”